# Corrigendum: Case Series: Maraviroc and pravastatin as a therapeutic option to treat long COVID/Post-acute sequalae of COVID (PASC)

**Authors:** Bruce K. Patterson, Ram Yogendra, Jose Guevara-Coto, Rodrigo A. Mora-Rodriguez, Eric Osgood, John Bream, Purvi Parikh, Mark Kreimer, Devon Jeffers, Cedric Rutland, Gary Kaplan, Michael Zgoda

PMC · DOI: 10.3389/fmed.2024.1375607 · Frontiers in Medicine · 2024-05-15

## Full-text entities

- **Diseases:** PASC (MESH:D000094024)
- **Chemicals:** pravastatin (MESH:D017035), Maraviroc (MESH:D000077592)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11135631/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11135631/full.md

---
Source: https://tomesphere.com/paper/PMC11135631